Alfred Health
Before COVID-19 struck, Natalia Rodriguez had been travelling from Launceston to The Alfred Oncology Unit every three weeks to take part in a clinical trial that could save her life.
Doctors at The Alfred were the only Australian researchers involved in an international randomised trial published in The Lancet that has shown patients live significantly longer when stereotactic ablative radiotherapy (SABR) is used to target all of their tumours.
Alfred Health Radiation Oncology experts have demonstrated the benefit of combining two forms of radiation treatment to target prostate cancer.
Australians will soon have greater access to potentially lifesaving treatments for rare cancers and other diseases with the establishment of a clinical trials network led by Alfred Health and Monash University.
A radiation therapy treatment that provides prostate cancer patients with an alternative to surgery is being acknowledged for 20 years of helping men at The Alfred.
Being told you have prostate cancer is a terrifying experience for many men – and it’s one Peter knows well. When he received his diagnosis, Peter was convinced he had just six months to live.
Cancer patients with multiple tumours are being given more time as strong evidence emerges about the best way to treat them using modern radiotherapy.
Researchers have shown artificial intelligence may one day automate melanoma diagnosis, with an international study revealing a fast-learning computer can outperform experienced dermatologists at detecting the deadly cancer.
When Alfred ICU and hyperbaric nurse Natalie McGregor was diagnosed with cancer, she found out how hard it was to be a patient – it left her emotionally and physically drained.
An effective treatment for prostate cancer is now being offered in Gippsland, with The Alfred launching its advanced seed brachytherapy program at Latrobe Regional Hospital this week.